Q2FY2016EarningsUpdate

11/15/15
www.apollohospitals.com

SAFEHARBOUR

No representation or warranty, express or implied, is made as to, and no

reliance should be placed on, the fairness, accuracy, completeness or
correctness of the information or opinions contained in this presentation.
Such information and opinions are in all events not current after the date of
this presentation. Certain statements made in this presentation may not be
based on historical information or facts and may be forward looking
statements based on the currently held beliefs and assumptions of the
management of the Company, which are expressed in good faith and in their
opinion reasonable, including those relating to the Companys general
business plans and strategy, its future financial condition and growth
prospects and future developments in its industry and its competitive and
regulatory environment.
Forwardlooking statements involve known and unknown risks, uncertainties
and other factors, which may cause the actual results, financial condition,
performance or achievements of the Company or industry results to differ
materially from the results, financial condition, performance or
achievements expressed or implied by such forwardlooking statements,
including future changes or developments in the Companys business, its
competitive environment and political, economic, legal and social
conditions. Further, past performance is not necessarily indicative of future
results. Given these risks, uncertainties and other factors, viewers of this
presentation are cautioned not to place undue reliance on these forward
looking statements. The Company disclaims any obligation to update these
forwardlooking statements to reflect future events or developments.
Numbers mentioned in this Presentation in respect of information provided
on hospital operating parameters and other operating metrics have been
compiled by the management and are being provided only by way of
11/15/15
www.apollohospitals.com

additional information. These are not to be construed as being provided

under any legal or regulatory requirements. The accuracy of these numbers
have neither been vetted nor approved by the Audit Committee and the
Board of Directors of Apollo Hospitals Enterprise Limited (AHEL), nor have
they been vetted or reviewed by the Auditors, and therefore may differ from
the actual.

Important risk factors and uncertainties could make a material difference to

the Companys operations. These risks include but are not limited to, the risk
factors described in AHELs prospectus, annual reports and other periodic
filings made by the company. The Company assumes no responsibility to
publicly amend, modify or revise any forward looking statement, on the
basis of any subsequent development, information or events, or otherwise.

This presentation is for general information purposes only, without regard to

any specific objectives, financial situations or informational needs of any
particular person. The Company may alter, modify or otherwise change in
any manner the content of this presentation, without obligation to notify
any person of such change or changes. This presentation may not be copied
or disseminated in any manner.

The Company on a quarterly basis adopts and publishes Standalone financial

results as per the stock exchange listing agreement requirements. The
consolidated financial results provided for the Quarter are unaudited and for
information purposes only.

Previous year figures have been reworked/regrouped /rearranged and

reclassified wherever necessary to conform to the requirement of revised
Schedule VI format
2

Contents

HIGHLIGHTS

STANDALONE
FINANCIAL
PERFORMANCE

11/15/15
www.apollohospitals.com

CONSOLIDATED
FINANCIAL
PERFORMANCE

OPERATIONAL
PERFORMANCE
HOSPITALS

OPERATIONAL
PERFORMANCE
STANDALONE
PHARMACY

UPDATEON
PROJECTS

UPDATEON
NONHOSPITAL
JVS

HIGHLIGHTS

11/15/15
www.apollohospitals.com

Highlights

1of2

Financial
Performance

Consolidated PAT of ` 1,892 mio in H1 FY16

Includes AHLL PAT loss of ` 153 mio

Chennai cluster displayed 13.2% increase in revenues in H1 FY16 at ` 6,866 mio as compared to ` 6,063 mio in H1 FY 15.
Hyderabad Revenues grew by 7.1% in H1 FY16 to ` 2,618 mio as compared to ` 2,445 mio in H1 FY15. However ARPOB
registered a healthy 15% growth due to case mix improvement and reduction in Low Yielding cases.
New Hospitals displayed good growth. Revenues grew from ` 767 mio in H1FY15 to ` 1,407 in H1FY16.Vanagaram & Jayanagar
have moved into positive EBITDA trajectory.
Bangalore region including Mysore have displayed a healthy revenue growth of 22%

11/15/15
www.apollohospitals.com

AHLL reported an EBITDA loss of ` 171 mio

H1 FY16 Consolidated EBITDA margin at 13.8% as compared to 14.5% in H1 FY 15

Key
Operational
Highlights

H1 FY16 Consolidated Revenues of ` 29,725 mio (up 18.1% yoy)

H1 FY16 Consolidated EBITDA of ` 4,095 mio (up 12.0% yoy)
New Hospitals reported an operating loss of ` 44 mio in H1 FY16

Stand Alone Pharmacies (SAP) reported Revenues of ` 11,032 mio, growth of 34%. SAP EBITDA at ` 403 mio (3.7% margin) in H1
FY16 .
Apollo Munich achieved a Gross Written Premium of ` 4,051 mio in H1 FY16 against ` 3,001 mio achieved during the same
period in the previous year representing a growth of 35%.

Highlights

2of2

Capacity

64 hospitals with total bed capacity of 8,985 beds as on Sep 30, 2015
40 owned hospitals including JVs/ Subsidiaries and Associates with 7,123 beds
11 Day care/ short surgical stay centres with 306 beds and 5 Cradles with 122 beds
8 Managed hospitals with 1,434 beds.
Of the 7,123 owned hospital beds capacity, 6,368 beds were operational and had an occupancy of 67%.
The total number of pharmacies as on Sep 30, 2015 was 2,217. Gross additions of 117 stores with 21 stores closures thereby
adding 96 stores on a net basis.

Medical
Initiatives
Accomplish
ments

Apollo Hospitals in Chennai successfully completes Asia's first enbloc combined heart and liver transplant
A team of Apollo doctors have successfully performed a complex pediatric liver transplant surgery on a 4year old child suffering
from a rare metabolic disorder.
Apollo Hospital, Madurai performed a rare surgery on a 15yearold boy by using endoscopy for excision of a vascular tumour in an
inaccessible area thereby sparing him of a permanent scar on his face by avoiding open surgery. The boy was discharged in three
days under this method against a hospitalization of at least 2 weeks under the conventional method.
The Government launched a health service called SEHAT (Social Endeavour for Health And Telemedicine) along with Apollo
Hospitals, which will connect 60,000 Common Service Centers (CSCs) across the country to a common network. This will greatly
improve the healthcare access to millions of citizens as they can visit a Common Service Centers (CSC) and fix an appointment for
seeking expert consultancy from doctors at Apollo Hospitals.

OtherKey
Developments

11/15/15
www.apollohospitals.com

Apollo Health City, Hyderabad, has been adjudged as the 'Best Medical Tourism Facility in India by the Government of India, for
the year 201314. This is the third time that the facility has won this award; having been conferred the award in the years 2009
2010 and 20112012 earlier.
Awarded the prestigious Porter Prize for Value Based Healthcare in recognition of its efforts towards redefining healthcare,
providing an overall framework for diagnostics, participating in building a resilient health care system, focusing on providing
value to patients and innovation in healthcare such as enhancing the patients experience.

STANDALONE
FINANCIALPERFORMANCE

11/15/15
www.apollohospitals.com

StandaloneFinancialPerformance Total

Revenue
OperativeExpenses
EmployeeExpenses
Administrative&OtherExpenses
TotalExpenses
EBITDA
margin(%)
Depreciation
EBIT
margin(%)
FinancialExpenses
OtherIncome
ProfitBeforeTax
ProfitAfterTax
margin(%)
ROCE(Annualized)(1)
CapitalEmployed
(1)

Q2FY15
11,529
6,088
1,795
1,920
9,803
1,726
15.0%
388
1,337
11.6%
201
82
1,218
915
7.9%

Q2FY16
13,673
7,326
2,047
2,368
11,742
1,932
14.1%
462
1,470
10.7%
309
45
1,206
937
6.9%

yoy(%)
18.6%
20.3%
14.1%
23.3%
19.8%
11.9%
84bps
18.9%
9.9%
85bps
53.2%
45.5%
1.0%
2.4%
109bps

(` mio)

H1FY15
22,066
11,620
3,502
3,655
18,777
3,289
14.9%
788
2,501
11.3%
391
147
2,257
1,742
7.9%

H1FY16
26,323
14,051
3,979
4,551
22,581
3,742
14.2%
912
2,830
10.8%
577
87
2,340
1,845
7.0%

14.0%
35,831

12.8%
44,205

yoy(%)
19.3%
20.9%
13.6%
24.5%
20.3%
13.8%
69bps
15.8%
13.2%
58bps
47.7%
40.9%
3.7%
5.9%
89bps

KeyHighlights
H1FY16Revenuesof` 26,323mio,
19.3%yoygrowth
H1FY16EBITDAat` 3,742mio,
13.8%yoygrowth
H1FY16EBITat ` 2,830mio,
13.2%yoygrowth
H1FY16PATat ` 1,845mio,
5.9%yoygrowth

Capital employed forthecalculationofROCEdoesnotincludeCapitalWorkinprogressonnewhospitalexpansionprojectsof` 7,461mioforH1FY16and` 6,197 mioforH1FY15&

investmentsinmutualfundsandassociates.
Previousyearfigureshavebeenreworked/regrouped/rearrangedandreclassifiedwherevernecessarytoconformtotherequirementofrevisedScheduleVIformat

11/15/15
www.apollohospitals.com

1of3

StandaloneFinancialPerformance Existing&NewBreakup

H1FY16

H1FY15
YOYGrowth
RevenueGrowth
EBITDARGrowth
EBITDAGrowth
EBITGrowth

Healthcare
Service
New
(Existing) Hospitals
Revenue
13,884
1,407
EBITDAR
3,638
77
margin(%)
26.2%
5.5%
EBITDA
3,383
44
margin(%)
24.4%
EBIT
2,770
247
margin(%)
20.0%
Revenue
13,064
767
EBITDAR
3,298
26
margin(%)
25.2%
3.3%
EBITDA
3,066
40
margin(%)
23.5%
EBIT
2,474
142
margin(%)
18.9%

11/15/15
www.apollohospitals.com

6.3%
10.3%
10.4%
12.0%

83.4%
202.1%

Healthcare
Services
(Total)
15,291
3,716
24.3%
3,339
21.8%
2,524
16.5%
13,832
3,323
24.0%
3,026
21.9%
2,333
16.9%

SAP

Standalone

11,032
766
6.9%
403
3.7%
306
2.8%
8,234
523
6.4%
263
3.2%
168
2.0%

26,323
4,481
17.0%
3,742
14.2%
2,830
10.8%
22,066
3,847
17.4%
3,289
14.9%
2,501
11.3%

10.6%
11.8%
10.4%
8.2%

34.0%
46.2%
53.2%
82.0%

19.3%
16.5%
13.8%
13.2%

(` mio)
KeyHighlights
HealthCareServicesrevenuegrowth
at10.6%from` 13,832mioinH1FY
15to ` 15,291mioinH1FY16
NewHospitalsrevenuesgrew83.4%
fromRs767mioinH1FY15toRs
1,407mioinH1FY16

ExistingHealthCareServicesrevenues
grew6.3%whileEBITDAmargins
increasedby90bpsfrom23.5%inH1FY
15to24.4%inH1FY16.

FY13Hospitals Vanagaram&
JayanagarreportedanEBITDAof
` 86mioinH1FY16.

FY14/FY15hospitals Trichy,Nashik,
Women&Child OMR,Nellore,
Perungudi,Women&Child SMRhave
anEBITDAlossof ` 130mio.

2of3

StandaloneFinancialPerformance SegmentReporting

Revenuesfromeachsegment
HealthcareServices*
StandalonePharmacy
OtherIncome
Total
Less:IntersegmentalRevenue
NetRevenues(incl.otherincome)
ProfitbeforeTax&Interest(EBIT)
HealthcareServices*
StandalonePharmacy
OtherIncome
TotalEBIT(incl.otherincome)
ProfitbeforeTax&Interest(EBIT)margins
HealthcareServices*
StandalonePharmacy
TotalEBITmargin(incl.otherincome)
InterestExpense
ProfitBeforeTax
CapitalEmployedHealthcareservices(1)
Healthcareservices ROCE(Annualized)

(` mio)

Q2FY15

Q2FY16

yoy(%)

H1FY15

H1FY16

yoy(%)

7,158
4,372
82
11,611
1
11,611

7,844
5,831
45
13,719
1
13,718

9.6%
33.4%
45.5%
18.2%

15,294
11,032
87
26,412
2
26,410

10.6%
34.0%
40.9%
18.9%

18.2%

13,834
8,234
147
22,214
2
22,212

1,241
96
82
1,419

1,305
164
45
1,514

5.2%
71.3%
45.5%
6.7%

2,333
168
147
2,647

2,524
306
87
2,917

8.2%
82.0%
40.9%
10.2%

17.3%
2.2%
12.2%
201
1,218

16.6%
2.8%
11.0%
308
1,206

119bps
53.2%
1.0%

16.9%
2.0%
11.9%
391
2,257
31,203
15.0%

16.5%
2.8%
11.0%
577
2,340
38,205
13.2%

88bps
47.7%
3.7%

KeyHighlights
HealthcareservicesRevenuesat
` 15,294mio,growthof10.6%
StandalonepharmaciesRevenues
at` 11,032mio,growthof34.0%.

18.9%

NewHospitals(Vanagaram,Jayanagar,
Trichy,Nasik,Women&Child OMR,
Nellore,Perungudi,Women&Child
SMR)havingcapitalemployedof
` 9,156mioyettocontributetoROCE.
ExistinghealthcareservicesRoCE
wasat19.1%inH1FY16as
comparedto18.6%inH1FY15

*HealthcareServicesconsistsofHospitals,HospitalBasedPharmaciesandConsulting
(1) Capital employed for the calculation of ROCE does not include Capital Work in progress on new hospital expansion projects of ` 7,461 mio for H1 FY 16 and ` 6,197 mio for H1 FY 15 & investments in mutual funds and associates.
Previous year figures have been reworked/regrouped/rearranged and reclassified wherever necessary to conform to the requirement of revised Schedule VI format

10

11/15/15
www.apollohospitals.com

3of3

10

CONSOLIDATED
FINANCIALPERFORMANCE

11

11/15/15
www.apollohospitals.com

11

ConsolidatedFinancialPerformance Total

IncomefromOperations
Add:ShareofJVs
TotalRevenues
EBITDA
margin(%)
EBIT
margin(%)
ProfitAfterTax
TotalDebt
Cash&Cashequivalents(includes
investmentinliquidfunds)
Standalonefinancials
TotalDebt
Cash&Cashequivalents(includes
investmentinliquidfunds)

Q2FY15
12,350
800
13,150
1,925
14.6%
1,380
10.5%
881

Q2FY16
14,632
894
15,526
2,120
13.7%
1,515
9.8%
1,095

yoy(%)
18.5%
11.8%
18.1%
10.1%
98bps
9.8%
74bps
24.3%

(` mio)

H1FY15
23,627
1,548
25,175
3,656
14.5%
2,590
10.3%
1,676

H1FY16
28,013
1,712
29,725
4,095
13.8%
2,937
9.9%
1,892
23,990

KeyHighlights

yoy(%)
18.6%
10.6%
18.1%
12.0%
75bps
13.4%
41bps
12.9%

Revenuegrowthof18.1%from
` 25,175mioinH1FY15to` 29,725
mioinH1FY16
ConsolidatedEBITDAgrewby12.0%
ConsolidatedEBITgrewby13.4%
ConsolidatedPATwasat` 1,892mio
inH1FY16

4,470

20,275
3,277

BasisofconsolidationintheAppendix(page23)
JVsincludeAhmedabad50%,Kolkata50%,PETCT 50%,ApolloMunich 10.23%,ApolloLavasa 37.50%,FutureParkingPvtLtd 49%,ApokosRehabPvtLtd50%

Previousyearfigureshavebeenreworked/regrouped/rearrangedandreclassifiedwherevernecessarytoconformtotherequirementofrevisedScheduleVIformat

12

11/15/15
www.apollohospitals.com

1of2

12

ConsolidatedFinancialPerformance Existing&NewBreakup Total

H1FY16

H1FY15

Revenue
EBITDAR
margin(%)
EBITDA
margin(%)
EBIT
margin(%)
Revenue
EBITDAR
margin(%)
EBITDA
margin(%)
EBIT
margin(%)

YOYGrowth
RevenueGrowth
EBITDARGrowth
EBITDAGrowth
EBITGrowth

13

11/15/15
www.apollohospitals.com

Healthcare
New
services
Hospitals
(Existing)
16,240
1,407
4,181
77
25.7%
5.5%
3,899
44
24.0%
3,115
247
19.2%
15,389
767
3,788
26
24.6%
3.3%
3,529
40
22.9%
2,743
142
17.8%
5.5%
10.4%
10.5%
13.6%

83.4%
202.1%

SAP

Munich

11,032
766
6.9%
403
3.7%
306
2.8%
8,234
523
6.4%
263
3.2%
168
2.0%

415
12
2.9%
7
1.8%
2
0.5%
364
10
2.7%
4
1.1%
0
0.1%

34.0%
46.2%
53.2%
82.0%

14.1%
21.1%
77.3%

AHLL
(incl
Cradle)
632
67
171
240
420
10
100
180

50.4%

(` mio)

2of2

KeyHighlights

Consol
29,725
4,969
16.7%
4,095
13.8%
2,937
9.9%
25,175
4,337
17.2%
3,656
14.5%
2,590
10.3%

Healthcareservice(existing)EBITDA
marginsincreasedfrom22.9%inH1FY
15to24.0%inH1FY16
SAPEBITDAof` 403mio(3.7%margin)
inH1FY16ascomparedto` 263mio
(3.2%margin)inH1FY15
AHLL Cradle&Clinicsreportedan
EBITDAlossof ` 171mioascompared
tolossof` 100mioinH1FY15

18.1%
14.6%
12.0%
13.4%

13

OPERATIONALPERFORMANCE
HOSPITALS

14

11/15/15
www.apollohospitals.com

14

OperationalPerformance Hospitals

(` mio)

AHELStandaloneHospitals
Total(5)
Particulars

Chennaicluster

Significant
subs/JVs/associates(2)

Others(1)

Hyderabadcluster

H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%) H1FY15 H1FY16 yoy(%)

No.ofOperatingbeds
Inpatientvolume
(3)

Outpatientvolume

6,073

6,368

1,342

1,505
44,489

930

930

1,694

1,814
47,650

14.0%

2,107

2,119

67,933

177,540 186,816

5.2%

40,825

9.0%

26,966

25,695

4.7%

41,816

68,982

1.5%

623,497 667,863

7.1%

186,840 206,208 10.4%

84,433

83,536

1.1%

124,704 138,874 11.4% 227,520 239,245

5.2%

InpatientALOS(days)

4.40

4.15

4.25

3.93

4.13

4.03

4.83

4.40

4.34

4.17

BedOccupancyRate(%)

70%

67%

71%

63%

65%

61%

65%

63%

76%

74%

Inpatientrevenue(` mio)

NA

NA

4,479

5,009

11.8%

2,000

2,124

6.2%

2,590

2,952

14.0%

6,590

7,062

7.2%

Outpatientrevenue(` mio)

NA

NA

1,585

1,857

17.2%

445

495

11.0%

455

546

19.9%

1,268

1,444

13.8%

25,155

27,933

34,924

39,315

12.6%

21,965

25,254

15.0%

15,068

16,667

10.6%

26,675

29,581

10.9%

NA

NA

6,063

6,866

13.2%

2,445

2,618

7.1%

3,045

3,498

14.9%

7,858

8,506

8.3%

(4)

ARPOB(` /day)

TotalNetRevenue(` mio)(4)

11.0%

Chennai&Hyderabadclusters

Chennaiclusterrevenuegrowthof13.2%
Revenuegrowthof7.1%inHyderabad
Others Revenue growth(14.9%) Inpatientrevenuegrowth(14.0%).19.9%

growthinOPRevenues.
SignificantSubsidiary/JV&AssociateHospitals Revenuegrowthof8.3%.
13%yoygrowthinBangalore&11%yoygrowthinAhmedabadand6%yoy
growthinKolkata.

Notes:
(1)OthersincludeMadurai,Karur,Karaikudi,Trichy,Mysore,Vizag,Karimnagar,Bilaspur,Bhubaneswar,Jayanagar&
Nashik.
(2) SignificantHospitalJVs/Subs/Associatesare Ahmedabad,Bangalore,Kolkata,Kakinada,Delhi&Indore(full
revenuesshownintableabove).
(3) OutpatientvolumerepresentsNewRegistrationsonly.
(4) ARPOBandNetRevenueisnetofdoctorfees.
(5) RevenuesundertheheadTotalhavenotbeenprovidedasConsolidatedactualresultswilldifferfromtotaldue
toproportionate consolidation.
*Inpatientvolumesarebasedondischarges.

Previousyearfinancialandoperationalnumbershavebeenregroupedandreclassifiedwherevernecessarytoconformwithcurrentyearclassificationandfullyearauditednumbers.

15

11/15/15
www.apollohospitals.com

15

OPERATIONALPERFORMANCE
STANDALONEPHARMACY

16

11/15/15
www.apollohospitals.com

16

OperationalPerformance StandalonePharmacy
Batch

Particulars
NoofStores
Upto
Revenue/store
FY08Batch
EBITDA/store
EBITDAMargin%
NoofStores
Revenue/store
FY09Batch
EBITDA/store
EBITDAMargin%
NoofStores
Revenue/Store
FY10Batch
EBITDA/store
EBITDAMargin%
TotalRevenues
TotalSAP(ExcludingHetero) EBITDA
EBITDAMargin%
NoofStores
Revenue/store
Hetero
EBITDA/store
EBITDAMargin%
No.OfStore
Revenue/Store
EBITDA/Store
Total
EBITDAMargin%
TotalRevenues
EBITDA
EBITDAMargin%
Capex(RsMio)
CapitalEmployed(RsMio)
TotalROCE%
TotalNo.ofEmployees

17

11/15/15
www.apollohospitals.com

Q2FY15
427
3.34
0.19
5.7%
191
3.06
0.10
3.3%
180
2.67
0.11
4.3%
4,372
143
3.3%

1,717
2.54
0.08
3.3%
4,372
143
3.3%
71
4,628
8.3%

Q2FY16
421
3.77
0.25
6.6%
187
3.56
0.18
5.0%
174
3.12
0.18
5.7%
5,515
224
4.1%
299
1.05
0.04
3.5%
2,217
2.63
0.10
3.6%
5,831
213
3.7%
108
6,000
10.9%

yoy(%)
12.9%
30.8%
91bps
16.3%
77.7%
172bps
17.0%
53.6%
135bps
26.1%
57.1%
80bps

3.4%
14.7%
36bps
33.4%
49.4%
39bps

H1FY15
427
6.43
0.37
5.8%
191
5.85
0.20
3.4%
180
5.12
0.23
4.5%
8,234
263
3.2%

1,717
4.79
0.15
3.2%
8,234
263
3.2%
119
4,628
7.3%
11,699

(` mio)
H1FY16
421
7.31
0.48
6.6%
187
6.88
0.33
4.8%
174
6.01
0.33
5.5%
10,564
419
4.0%
299
1.56
0.06
3.6%
2,217
4.98
0.18
3.6%
11,032
403
3.7%
169
6,000
10.2%
13,731

yoy(%)

KeyHighlights

13.7%
29.5%
80bps

Revenuesat` 11,032mio,growthof34%

17.7%
66.7%
140bps

EBITDAof` 403mioinH1FY16as
comparedto` 263mioinH1FY15,growth
of53.2%
EBITDAmarginsof3.7%inH1FY16
ascomparedto3.2%inH1FY15

17.4%
43.9%
101bps
28.3%
59.5%
78bps

ExcludingtheHeteronetworkofstores,
Revenuegrowthwas28%andEBITDA
growthwas59%,EBITDAmarginof4.0%
inH1FY16
LFL(Likeforlike)Revenueperstore
growthforpreFY2010batchofstores
inH1FY16is15.4%(yoy)andEBITDA
perstoregrowthis38.1%(yoy).EBITDA
marginof5.9%inH1FY16ascompared
to5.0%inH1FY15

3.8%
18.1%
44bps
34.0%
53.2%
46bps

ROCEinH1FY16at10.2%ascompared
to7.3%inH1FY15
Grossadditionof117storesandclosed26storesinH1FY16
Netadditionof91stores.
No.ofstoresason30th Sep2015is2,217
17

UPDATEONPROJECTS

18

11/15/15
www.apollohospitals.com

18

KeyHospitalExpansionPlan&UpdateonExecution

Location

CoD*

(` mio)

TotalEstimated
ProjectCost(INR
TypeofHospital No.OfBeds
mn)

KeyHighlights
Weareinthefinalstagesofour
currentexpansionplans

AdditioninFY16
NaviMumbai

FY16

SuperSpecialty

400

5,250

NorthBangalore

FY16

SuperSpecialty

180

925

Vizag

FY16

SuperSpecialty

250

1,494

Indore(Expansion)

FY16

SuperSpecialty

65

280

895

7,949

175

2,000

SubTotal

1,300bedsin9locationscommissioned
inthelast24months Vanagaram260,
Jayanagar140,Trichy200,Nashik125,
WomenandChild OMR60,Indore120,
Nellore190,Perungudi150,Women&
Child SMR50
Toadd895bedsin3locationsinFY16
NorthBangalore180,NaviMumbai
400,Indore65&Vizag250

AdditioninFY19
SouthChennai

FY19

Proton

FY19

Byculla,Mumbai

FY19

SubTotal
Total

SuperSpecialty

4,200
SuperSpecialty

300

1,400

475

7,600

1,370

15,549

Toaddanother475bedsinFY19 South
Chennai175,SouthMumbai300.
Focus now is on operationalising the
new capacity and growing and
consolidating our leadership position in
these markets in the next 18 24
months

ThetotalCAPEXestimatedforthisexpansionplanisRs1,555crore.OfthisInvestmentofRs724crorealreadymade.Balancewillbeinvestedbya
mixofinternalaccrualsandtheproposedrightsIssue.

19

Expecteddateofcompletion

11/15/15
www.apollohospitals.com

19

UPDATEONNON
HOSPITALJVS

20

11/15/15
www.apollohospitals.com

20

UpdateonnonhospitalJVs

(` mio)
KeyHighlights

ApolloMunichHealthInsuranceCoLtd
Particulars
TotalIncome
EBITDA
margin(%)
ProfitafterTax
margin(%)

Q2FY15
1,799
34
1.9%
16
0.9%

Q2FY16
2,093
78
3.7%
48
2.3%

yoy(%)
16.3%
127.6%
181bps
192.7%
138bps

H1FY15
3,557
40
1.1%
2
0.1%

H1FY16
4,058
71
1.8%
20
0.5%

yoy(%)
14.1%
77.3%
63bps

DuringH1FY16,thecompanyachieved
aGrossWrittenPremium(GWP)of
` 4,051mioagainstaGWPof` 3,001
mioinH1FY15

725.9%
43bps

EBITDAof` 71mioinH1FY16as
comparedtoEBITDAof` 40mioinH1
FY15
PATof ` 20mioinH1FY16in
comparisonto ` 2mioin
H1FY15.
Theincurredclaimlossratiowasat
66.5%inH1FY16

TheAssetsunderManagementstood
at` 7,162mioasonSep30,2015

TheCompanynowhas85officesacross
thecountry

Previousyearfigureshavebeenreworked/regrouped/rearrangedandreclassifiedwherevernecessarytoconformtotherequirementofrevisedScheduleVIformat

21

11/15/15
www.apollohospitals.com

21

22

11/15/15
www.apollohospitals.com

22

Appendix:BasisofConsolidation
AHELStandalone

Location

Description

AHEL
Ownership

Subsidiaries

Location

ChennaiMain

Chennai

Hospital

SamudraHealthcareEnterprisesLtd.

Kakinada

ASH Chennai

Chennai

Hospital

ApolloHospitals(UK)Ltd

Tondiarpet Chennai

Chennai

Hospital

ImperialHospitalandResearchCentreLtd.

FirstMed Chennai

Chennai

Hospital

ApolloChildren'sHospital

Chennai

ApolloSpecialty,Vanagaram

Chennai

Description

AHEL
Ownership

Hospital

100.0%

UK

Hospital

100.0%

Bangalore

Hospital

90.0%

PinakiniHospitalsLtd.

Nellore

Hospital

79.4%

Hospital

UniqueHomeHealthcareLimited

Chennai

ParamedicalServices

100.0%

Hospital

ApolloHealthandLifestyleLtd.

Hyderabad

ApolloClinics

100.0%

Women&Child,OMR

Chennai

Hospital

ABMedicalCentresLimited

Chennai

Infrastructure

100.0%

ASHPerungudi

Chennai

Hospital

WesternHospitalsCorporationPvtLtd

Belapur

Hospital

100.0%

Women&Child,ShafeeMohammedRoad

Chennai

Hospital

SapienBiosciensesPvtLtd

Hyderabad

Biobankingtissues

70.0%

Madurai

Madurai

Hospital

ApolloRajshreeHospital

Indore

Hospital

57.7%

Karur

Karur

Hospital

Karaikudi

Karaikudi

Hospital

Trichy

Trichy

Hospital

Nellore

Nellore

Hospital

100.0%

JVs

Location

ApolloHospitalsInternationalLtd.

Description

Ahmedabad

Hospital

50.0%

ApolloGleneaglesHospitalsLtd.

Kolkata

Hospital

50.0%

ApolloGleneaglesPETCTPvt.Ltd.

Hyderabad

Hospital

50.0%

Hyderabad

Hyderabad

Hospital

ApolloMunichHealthInsuranceCompanyLtd

Bilaspur

Bilaspur

Hospital

ApolloLavasaHealthCorporationLtd

Maharashtra Hospital

37.5%

HealthInsurance

10.2%

Mysore

Mysore

Hospital

FutureParkingPvtLtd

Chennai

Infrastructure

49.0%

Vizag

Vizag

Hospital

ApoKosRehabPvtLtd

Hyderabad

RehabCentre

50.0%

KarimNagar

KarimNagar

Hospital

Bhubaneswar

Bhubaneswar

Hospital

Jayanagar

Bangalore

Hospital

Nashik

Nashik

Hospital

23

11/15/15
www.apollohospitals.com

Associates

Location

IndraprasthaMedicalCorporationLtd.
FamilyHealthPlanLtd.
StemcyteIndiaTherapauticsPvtLtd

Delhi,Noida
Ahmedabad

23

Description
Hospital
TPA,HealthInsurance
StemcellBanking

22.0%
49.0%
24.5%

Hospitals UnderstandingKeyOperatingMetrics
Description

24

Formula/Calculation

KeyDriver

OperatingBeds

Numberofoperatingbeds

Occupancy

InpatientBedDays

InpatientBedDaysBilled

ALOS

AverageLengthofStayper
Inpatient

InPatientBedDays/
InPatientAdmissions

CaseMix/Typeofprocedures
Leveragetechnologyandquality
ofclinicalcaretoshortenstay

ARPOB/day

AverageRevenuePer
OccupiedBedDay

(IPRevenue*+
OPRevenue+HospitalBased
PharmacyRevenue)/
IPBedDays

CaseMix/Typeofprocedures
Betterutilizationofoperational
theatres,medicalequipment
Pricing

Contribution

Contribution

Revenue Variablecosts

Purchasingefficiency
Operatingefficiency

Projectexecution
CapitalExpenditure
Brand
Doctorreputation
Qualityofoutcomes
Competition

ApollodoesnotincludeconsultantfeeinitsIPRevenuereportingasconsultantsatApollooperateonafeeforservicemodel.

11/15/15
www.apollohospitals.com

24

THANKYOU

25

11/15/15
www.apollohospitals.com

25